Please login to the form below

Not currently logged in
Email:
Password:

China

This page shows the latest China news and features for those working in and with pharma, biotech and healthcare.

ACPs to lead gene therapies in haemophilia market growth

ACPs to lead gene therapies in haemophilia market growth

GlobalData found that key opinion leaders in the eight major markets (the US, France, Germany, Italy, Spain, UK, Japan, and China) are highly optimistic about these therapies and agree that they

Latest news

More from news
Approximately 95 fully matching, plus 499 partially matching documents found.

Latest Intelligence

  • Is anybody listening? Is anybody listening?

    Similarly, authorities in Germany, China, Russia and Australia – as well as the EU in general – are all taking measures to clamp down on companies that aren’t doing enough to fulfil

  • Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019 Orphan drugs and breakthrough therapies drive Cortellis Drugs to Watch 2019

    The first-in-class inhibitor of hypoxia- inducible factor-prolyl hydroxylase, or HIFPH, was approved in December 2018 in China for the treatment of CKD-related anaemia in patients dependent on

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    The approach is however also set to be tested as an in vivo therapy for cervical cancer caused by human papillomavirus (HPV) by researchers in China, who are comparing a TALEN ... All told, what is clear is that while He’s experiment has backfired

  • Unlocking the potential of science and technology in the UK Unlocking the potential of science and technology in the UK

    2.2%) and China 2.07%) are already making a bigger commitment to R&D. ... The UK is a small country, with distances between the respective science and tech clusters insignificant compared to, say, the USA or China.

  • China’s clinical trial shake-up China’s clinical trial shake-up

    On paper, China offers a huge patient population that accelerates clinical trial timelines. ... Now however, China is making changes that could finally unlock its full potential.

More from intelligence
Approximately 17 fully matching, plus 109 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 35 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 55 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

CBC
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK...
Tactful screening & participant sensitivity
Screening participants can involve asking personal questions that could be perceived as intrusive. Here CMR explores the implications of such lines of questioning....
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

Infographics